US Cellulite Market Trends
The size of the US cellulite market was estimated at $ 570.64 million in 2024 and is expected to increase to CAGR 9.7% from 2025 to 2033. Social and psychological challenges associated with obesity, such as stigma, prejudice, and prejudice. People with obesity often deal with bullying, social exclusion and limited access to educational and employment opportunities. For example, a publication by Novo Nordisk emphasizes that people with obesity are often distinguished in professional and academic environments. These social pressures contribute significantly to the growing demand for US cellulite processing solutions
Minimally invasive surgeries quickly replace invasive surgeries. For example, according to the US Society of Plastic Surgeons, 25.4 million cosmetics were carried out in 2023, of which 0.74 million were non -invasive fat reduction procedures. Thus, the increase in the adoption of minimally invasive surgeries, coupled with the availability of a wide range of minimally invasive therapeutic options, leads to the development of the market for US cellulite.
Increasing the sedentary lifestyle and obesity has significantly increased the prevalence of cellulite. According to the CDC, almost 42% of US adults were obese, with many states showing obesity rates exceeding 35%. Excess adipose tissue contributes to the development of cellulite, urging more people to seek cosmetic treatments. This trend is further enhanced by the growing consciousness of health and the desire for self-care, translating into increased demand for solutions that offer smoother, milder skin, and even in the absence of invasive surgery.
In recent years they have noticed rapid innovation in non -invasive and minimal invasive technologies, such as radio frequency techniques, lasers, ultrasound, cryolipolysis and hypoteschism such as the cellular offering of effective results with minimal interruption. Consumers are increasingly favoring external patients and local/domestic treatment options that are lined with busy programs and ease of access. These technologies, backed by the increase in available income and training directly by the consumer, have made cellulite treatments more common and affordable, leading to market expansion.
Procedures
The non -invasive treatment department holds the largest share of 36.8% in 2024 due to the increasing preference of procedures that provide visible results without surgery, scars or extensive recovery time. Consumers are increasingly looking for aesthetic improvements that are safe, fast and require little to delayed, especially professionals and millennia. This demand is in line with the development of Medspas clinics and external patients dermatology offering radio frequency processes, based on laser, ultrasound and cryolipolysis that effectively target cellulite. In addition, the increasing rate of obesity and aesthetic concerns associated with aging have led more people to seek non -body border surgical options, making non -invasive treatments the preferred method of cellulite management.
Technological innovation continues to promote the non -invasive forward section, with companies developing next -generation devices that offer multiple capabilities, combining energy therapies with mechanical massage, lymphatic stimulation or space -assisted technology. The popularity of processed FDA treatments such as Cellulaze, Cellfina and QWO (collagenase Clostridium Histolyticum-aaes) also contributed to increasing confidence in non-invasive approaches.
Cellulite
The Soft Cellulite department deposited the largest share of 46.4% in 2024 due to its highest predominance between women aging and after menopause. Soft cellulite usually occurs more obviously when the skin loses elasticity and collagen, which is common with age and hormonal changes. This has increased the demand for aesthetic remedies that target skin looseness and fat accumulation. Increasing awareness of body aesthetics, especially among women aged 35-60 years, has fueled the development of non-invasive solutions adapted to soft cellulite. In addition, soft cellulite is easier to treat with local factors, energy -based devices and massage treatments, making it more commercially accessible or edema.
Manufacturers also start targeted products such as anti-cellulite creams with retinol, caffeine and peptides, many of which are commercially available for soft cellulite. Combined with marketing that focuses on lifestyle and the increased influence of social media, these factors have secured the dominance of soft cellulite on the treatment market.
Final use of ideas
The Department of Clinics and Beauty Centers holds the largest share of 65.2% in 2024. Cellulite development is usually observed in women aged 20 and older and is mainly considered a cosmetic concern. As a result, many people seek treatment through aesthetic centers. Both beauty and hospitals offer effective solutions for cellulite, but the growing prevalence of cellulite and other aesthetic issues has led to increased demand for specialized beauty centers and clinics. In many cases, hospitals refer to patients in these facilities for focused cosmetic treatments, further growth and extension of the role of aesthetic clinics in the landscape of cellulite treatment.

In addition, while some people choose home solutions, such as Over-Counter (OTC) creams for the management of cellulite, many prefer professional treatments in clinical and thermal baths, where specialized staff and certified professionals contribute to minimizing the risk of complications. The global development of clinics and medical healing is further supported by relatively loose regulatory requirements for non -surgical cosmetic procedures, which continue to lead to market expansion.
Key to US Cellulite Therapy Companies:
- Merz pharma
- Hologic, Inc. (Cynosure)
- Medical partner
- Aesthetic zimmer
- Alma lasers
- Supplication
- Novel
- Abbvie
- Hibernation
Recent developments
Scope of the treatment market with cellulite cellulite
|
Feature
|
Details
|
|
Purchase size value in 2025
|
US $ 633.0 million
|
|
Revenue Revenue in 2033
|
US $ 1,326.3 million
|
|
Growth rate
|
CAGR 9.7% from 2025 to 2033
|
|
Base Year for Estimation
|
2024
|
|
Historical data
|
2021 – 2023
|
|
Prediction period
|
2025 – 2033
|
|
Quantitative units
|
Revenue in Millions of Dollars/Billions and CAGR from 2025 to 2033
|
|
Coverage
|
Revenue forecast, company ranking, competitive landscape, growth factors and trends
|
|
Sections are covered
|
Process, cellulite, final use
|
|
Scope
|
US
|
|
Basic companies
|
Merz Pharma? Hologic Inc. (Cynosure); Syneron Medical? Zimmer Aesthetics? Alma Lasers? Cymedics? Nubway? Abbvie? Hibernation
|
|
Adaptation field
|
Free reference adjustment (equivalent to 8 working days of analysts) with purchase. Add or change the country, the regional and the field of application of the department.
|
|
Pricing and Purchase Options
|
Use customized market options to meet your exact research needs. Explore market options
|
The division of market market market cellulite cellulite
This report provides for the increase in revenue to country levels and provides an analysis of the latest industry trends in each of the subtractions from 2021 to 2033. For this study, Grand View Research has been fragmented by the cellulite market exposure to the process of cellulite, cellulite and final use:
-
Procedure Outlook (revenue, millions of dollars, 2021 – 2033)
-
Cellulite Outlook (revenue, millions of dollars, 2021 – 2033)
-
Soft cellulite
-
Tough cellulite
-
Edema of cellulite
-
-
Final useOutlook (revenue, millions of dollars, 2021 – 2033)
Frequently Asked Questions about this report
si. The size of the US cellulite market was estimated at US $ 570.6 million in 2024 and is expected to reach $ 633.0 billion in 2025.
si. The US cellulite treatment market is expected to rise at an annual growth rate of 9.7% from 2025 to 2033 to reach $ 1.3 billion by 2033.
si. The non -invasive treatment department holds the largest share of 36.8% in 2024 due to the increasing preference of procedures that provide visible results without surgery, scars or extensive recovery time.
si. Some of the players active in this market are Merz Pharma, Hologic Inc. (Cynosure), Syneron Medical, Zimmer Aesthetics, Alma Lasers, Cymedics, Nubway, AbbVie, Cutera.
si. The key factors that lead to cellulite cellulite growth include the increasing preference for cosmetic and aesthetic therapies, along with an increase in obesity rates, promote market expansion. The social and psychological challenges associated with obesity, such as stigma, weight -based prejudices, emotional discomfort and reduced self -confidence, appear as key guides.
